Filing Flows › Kura Oncology (KURA) › Stock forecast & fair value
Kura Oncology (KURA) stock forecast and price target
Kura Oncology (KURA) trades at $7.27. 13 analysts' median price target is $28.00 (+285%), from $15.00 to $76.00.
Kura Oncology's latest quarter
Kura Oncology, Q2 2026: revenue $20.9M (+36% year over year), operating margin -349.8%, net loss $68.3M, operating cash flow −$62.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for KURA stock?
The median of 13 analysts' 12-month targets is $28.00, +285% from $7.27; the range is $15.00 to $76.00. The average rating is strong buy.
Does Kura Oncology usually beat earnings estimates?
It beat the consensus EPS estimate in 33% of the quarters on record.
Is KURA stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.